Search

The growth and intensity of higher education R&D (HERD) expenditures varies considerably across metropolitan areas, a recent SSTI analysis of National Science Foundation data finds. New York ($4.3 billion), Boston ($3.2 billion), and Baltimore ($2.9 billion) had the highest overall levels of HERD expenditures in 2016. In that same year, Ithaca, New York (19.1 percent), State College, Pennsylvania (9.5 percent), and College Station, Texas (9.4 percent) had the highest levels of HERD intensity – measured as the share of HERD expenditures to gross metropolitan product.

Every state government invested at least $1.0 million in research and development in FY 2017, according to recent data from the National Science Foundation’s National Center for Science and Education Statistics. During the three-year period from FY 2015 to FY 2017, California ($551.8 million per year), New York ($403.2 million per year), and Texas ($244.9 million per year) state governments averaged the most R&D expenditures. In FY 2017, these three states accounted for 49.8 percent of the national total, up from 45.6 percent of the total invested by state governments in 2012.

One of the best ways to measure the effectiveness of state programs intended to encourage the success of SBIR applications is the approval-rate of their submissions. Although this data has been historically unavailable across every federal agency, it is now accessible for the National Institutes of Health (NIH), the second largest provider of SBIR/STTR awards, according to a 2018 Digest report. The NIH distributed $446.2 million in SBIR/STTR awards in 2017, with every state except North and South Dakota receiving an award. Although California and Massachusetts had the most successful SBIR/STTR applications in 2017, accounting for roughly one-third of the total when combined, neither state ranked among the top 10 in success rate. NIH SBIR/STTR applications in Oregon (29 percent success rate), Vermont (25 percent success rate), and Wisconsin (23 percent success rate) were the most likely to be approved over the ten-year period from 2008 to 2017. Each of these states, as well as many others with high success rates, offer assistance with proposals such as technical support programs and Phase 0 grants.

For the first time, the U.S. Bureau of Economic Analysis has released prototype gross domestic product (GDP) data at the county level. This preliminary data, which includes the years 2012 to 2015, provides a granular look at county-level productivity. Furthermore, standardizing this data by population – GDP per capita – makes it a useful metric for comparing counties over time and across the country.  From 2012 to 2015, per capita GDP grew in 82 percent of counties.

Higher education R&D expenditures (HERD) grew by 38.9 percent from 2008 to 2017, an increase of more than $21 billion, according to an SSTI analysis of recently released data from the National Science Foundation’s National Center for Science and Engineering Statistics. From 2016 to 2017, HERD grew by $3.8 billion, the largest year-over-year increase since 2010-2011.

Since 2011, more than half of the nation's new investment in business research and development has come from California companies, and more than three-quarters has come from the top five states, according to an SSTI analysis of recently released NSF data.

Across the country, there are nearly 6.9 million scientists and engineers, representing 4.8 percent of the nation’s workforce. There are 20 states having at least 100,000 workers in these occupations. Scientists and engineers are concentrated around the nation’s capital, making up the largest share of the workforce in Washington D.C., Maryland, and Virginia. From 2003 to 2017, the number of scientists and engineers grew the fastest in Arkansas, North Dakota, and Utah.

NVCA and PitchBook released Venture Monitor 3Q 2018 this week. The highlight data point in the report is that total U.S. venture capital investment in 2018 is on pace to break $100 billion for the year — and, in fact, to break $110 billion. At the same time, deal volume is on pace to be at the lowest level since 2012, with just 6,583 deals reported to date in 2018.

State and local governments invested $3.8 billion in R&D at institutions of higher education in FY 2015, with the top ten states accounting for $2.3 billion – roughly 59.4 percent of overall spending, according to an SSTI analysis of NSF data. From FY 2011 to FY 2015, total spending remained relatively unchanged (0.1 percent decrease). Over that same period, colleges and universities in 25 states reported increased expenditures from state governments, while 25 and the District of Columbia reported declines.

Companies employing more than 5,000 people represent nearly two-thirds (63.9 percent) of all business R&D in the United States, according to an analysis of NSF’s Business Research, Development, and Innovation Survey (BRDIS). With the recent release of more detailed numbers and to expand on a Useful Stats report from earlier this year, this analysis focuses on business R&D by company size.

Federal funding for S&E R&D grew by $7.2 billion from 2002 to 2016, reaching more than $31.6 billion. This represents a 29.4 percent increase during the period, or approximately 2.0 percent per year, according to an SSTI analysis of data from the National Science Foundation’s National Center for Science and Engineering Statistics.

Real personal income — a measure of purchasing power that connects income to costs — has grown within states at an average rate of 1.5 percent per person since 2012, according to data from the Bureau of Economic Analysis. The average American’s experienced income growth, however, appears to vary wildly depending on location.

Note: this article has been updated.

Last week, SSTI looked at recently released data on venture capital dollars and deals by state, finding that total investment has skyrocketed but remains heavily concentrated in a few markets. This week we examine this data through two additional lenses: VC investment intensity and VC investment per technology startup.

Over the five-year period from 2012 to 2017, as total venture capital investments more than doubled, growing from $41.2 billion to $84.0 billion, the number of deals increased by just 2.7 percent according to new data from the NVCA-Pitchbook Venture Capital Monitor. In 2017, more than half of all venture capital deals and three-quarters of all venture capital dollars went to companies in California, New York, and Massachusetts in 2017.

Last week, SSTI examined the geography of “America’s Seed Fund,” the SBIR/STTR awards, on a state-by-state basis. A look at how the more than 25,500 awards were distributed at the regional level over the five-year period from 2013 to 2017 yields additional insight. The metropolitan areas with the largest concentrations of SBIR/STTR awards include knowledge hubs with large universities and access to federal R&D, such as Boston, Los Angeles, and Washington D.C.

The SBIR/STTR program, which dubs itself as “America’s Seed Fund,” is one of the broadest forms of early-stage capital available to small technology companies. During the five-year period from 2013 to 2017, the 11 federal agencies participating in the SBIR/STTR program distributed 25,524 awards. Using charts, maps, and a downloadable spreadsheet, this Digest article looks at trends in SBIR/STTR awards by state over the period, including the companies with the most awards and states where SBIR/STTR awards outnumber VC deals.

Across the country, companies reported nearly $300 billion in self-funded and self-performed domestic R&D in 2015, according to recent data from the National Science Foundation’s Business R&D and Innovation Survey (BRDIS), with nearly one-third of this total ($95.0 billion) coming from California. Businesses in Wyoming, Washington D.C., and Utah reported the greatest increase in self-funded and self-performed R&D from 2010 to 2015.

As explored in last week’s Digest, the presence of Eds and Meds institutions can positively influence the levels of human capital in a region, but the need to keep costs low can hinder their overall growth. SSTI’s analysis subsequently found that employment in Eds and Meds industries increased in every state from 2005 to 2015. This article looks at Eds and Meds employment for the largest metropolitan areas in the United States. Mid-sized regions in the Northeast like Rochester, New York (4.4 percentage points), New Haven, Connecticut (2.9 percentage points), and Harrisburg, Pennsylvania (2.3 percentage points) experienced the largest growth in per-capita employment in Eds and Meds industries between 2010 and 2015.

For decades, state and local economies have leaned heavily on their anchor institutions during times of economic uncertainty and transition. An analysis finds that total employment in “Eds and Meds” industries increased in every state from 2005 to 2015. This article breaks down the growth and geography of Eds and Meds employment at the state level, while next week’s issue of the Digest will explore this data by metropolitan area.

Last week, The Digest covered newly released data from the National Science Foundation’s National Center for Science Education Statistics, which found that for the first time in five years, federal funding for higher education research and development increased in both current and constant dollars.

An aging, more diverse workforce is what the Bureau of Labor Statistics foresees in the coming decade, with a declining participation rate, which may in turn restrict economic growth. The new projections released this week echo the downward trend in the rate of labor force participation since the peak of 67.3 percent in early 2000. While recent trends show an increasing level of participation among the 55+ crowd, there has been a decreasing level of participation among 16 to 24-year-olds as school enrollment has increased, as well as a continuing decline among the prime working-age cohort of 25 to 54-year-olds.

An SSTI analysis of the labor force participation rate of the prime age workers for each state revealed a great amount of variation among the states. The map below shows the participation rate for this cohort averaged out over 2014-2016 to account for yearly fluctuations.

With a focus on improving health, driving economic growth, and expanding the country’s research capacity, the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services is the largest public funder of biomedical research in the world. Because of NIH’s central role in supporting science, technology, and innovation, a better understanding of the agency’s footprint may be helpful to the technology-based economic development practitioner community.

Once again, more than three-quarters of U.S. venture capital (VC) dollars went to companies in California, New York and Massachusetts in 2016, according to data from the PricewaterhouseCoopers (PwC)/CB Insights’ Moneytree Report Explorer. Approximately 53.3 percent of all VC capital went to California companies, down nearly 4.4 percent from the states peak in 2014 (57.7) and down 3.9 percent from 2015.

In FY 2013, the federal government obligated $25.9 billion for science and engineering research and development (S&E R&D) at colleges and universities, a decrease of $1.6 billion from FY 2012 (5.7 percent). Eight states (California, New York, Maryland, Pennsylvania, Massachusetts, Texas, North Carolina, and Illinois) each received more than $1 billion in funding during FY 2013, though each state also experienced a decrease from their FY 2012 total.